Co-treatment with hepatocyte growth factor and TGF-beta1 enhances migration of HaCaT cells through NADPH oxidase-dependent ROS generation.

Source:http://linkedlifedata.com/resource/pubmed/id/20177149

Exp. Mol. Med. 2010 Apr 30 42 4 270-9

Download in:

View as

Triples

General Info

PMID
20177149